Since relatively high circulating IGF-1 concentration is associated with increased cancer risk [18]-[19], modulation of IGF-1 levels by soy isoflavone intake may be implemented as a risk reduction mechanism, particularly for breast cancer as reported in our previous studies [38]-[39]. The gene discussed is IGF1; the disease is breast carcinoma.